speb/financial-data huggingface dataset:
EBM.V balance_sheet (quarterly, 2024-10-31) — Cash Financial: 0.00
EBM.V cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Financing Activities: -4619.00
EBM.V cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Financing Activities: -6531.00
EBM.V cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Operating Activities: -15217.00
EBM.V cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Operating Activities: -7872.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Account Payable: -26278.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Other Working Capital: -55657.00
EBM.V cash_flow (quarterly, 2024-10-31) — Change In Other Working Capital: 361393.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Payable: 347375.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Payables And Accrued Expense: 347375.00
EBM.V cash_flow (quarterly, 2024-10-31) — Change In Payables And Accrued Expense: -277214.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Prepaid Assets: 48936.00
EBM.V cash_flow (quarterly, 2024-10-31) — Change In Prepaid Assets: 49732.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Receivables: -28417.00
EBM.V cash_flow (quarterly, 2024-10-31) — Change In Receivables: -5432.00
EBM.V cash_flow (annual, 2024-10-31) — Change In Working Capital: 312237.00
EBM.V cash_flow (quarterly, 2024-10-31) — Change In Working Capital: 128479.00
EBM.V cash_flow (annual, 2024-10-31) — Changes In Cash: -19836.00
EBM.V cash_flow (quarterly, 2024-10-31) — Changes In Cash: -14403.00
EBM.V balance_sheet (annual, 2024-10-31) — Common Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Common Stock: 4687376.00
EBM.V balance_sheet (annual, 2024-10-31) — Common Stock Equity: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: -1296666.00
EBM.V income_statement (annual, 2024-10-31) — Cost Of Revenue: 247687.00
EBM.V income_statement (quarterly, 2024-10-31) — Cost Of Revenue: 80807.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Assets: 43680.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Assets: 43680.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Debt: 79608.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Debt: 79608.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Debt And Capital Lease Obligation: 79608.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Debt And Capital Lease Obligation: 79608.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Deferred Liabilities: 16619.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Deferred Liabilities: 16619.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Deferred Revenue: 16619.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Deferred Revenue: 16619.00
EBM.V balance_sheet (annual, 2024-10-31) — Current Liabilities: 1570959.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Current Liabilities: 1570959.00
EBM.V cash_flow (annual, 2024-10-31) — Depreciation: 107542.00
EBM.V cash_flow (annual, 2024-10-31) — Depreciation Amortization Depletion: 107542.00
EBM.V cash_flow (quarterly, 2024-10-31) — Depreciation Amortization Depletion: 27636.00
EBM.V income_statement (annual, 2024-10-31) — Depreciation Amortization Depletion Income Statement: 107542.00
EBM.V income_statement (quarterly, 2024-10-31) — Depreciation Amortization Depletion Income Statement: 27636.00
EBM.V cash_flow (annual, 2024-10-31) — Depreciation And Amortization: 107542.00
EBM.V cash_flow (quarterly, 2024-10-31) — Depreciation And Amortization: 27636.00
EBM.V income_statement (annual, 2024-10-31) — Depreciation And Amortization In Income Statement: 107542.00
EBM.V income_statement (quarterly, 2024-10-31) — Depreciation And Amortization In Income Statement: 27636.00
EBM.V income_statement (annual, 2024-10-31) — Diluted Average Shares: 68885969.00
EBM.V income_statement (annual, 2024-10-31) — Diluted EPS: -0.01
EBM.V income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Diluted NI Availto Com Stockholders: -155944.00
EBM.V balance_sheet (annual, 2024-10-31) — Duefrom Related Parties Current: 0.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Duefrom Related Parties Current: 0.00
EBM.V balance_sheet (annual, 2024-10-31) — Dueto Related Parties Current: 1399275.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Dueto Related Parties Current: 1399275.00
EBM.V income_statement (annual, 2024-10-31) — EBIT: -437700.00
EBM.V income_statement (quarterly, 2024-10-31) — EBIT: -150316.00
EBM.V income_statement (annual, 2024-10-31) — EBITDA: -330158.00
EBM.V income_statement (quarterly, 2024-10-31) — EBITDA: -122680.00
EBM.V cash_flow (annual, 2024-10-31) — End Cash Position: -1388.00
EBM.V cash_flow (quarterly, 2024-10-31) — End Cash Position: -1388.00
EBM.V cash_flow (annual, 2024-10-31) — Financing Cash Flow: -4619.00
EBM.V cash_flow (quarterly, 2024-10-31) — Financing Cash Flow: -6531.00
EBM.V cash_flow (annual, 2024-10-31) — Free Cash Flow: -15217.00
EBM.V cash_flow (quarterly, 2024-10-31) — Free Cash Flow: -7872.00
EBM.V income_statement (annual, 2024-10-31) — Gain On Sale Of Security: -7205.00
EBM.V income_statement (quarterly, 2024-10-31) — Gain On Sale Of Security: -11603.00
EBM.V balance_sheet (annual, 2024-10-31) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V income_statement (annual, 2024-10-31) — General And Administrative Expense: 524070.00
EBM.V income_statement (quarterly, 2024-10-31) — General And Administrative Expense: 121963.00
EBM.V balance_sheet (annual, 2024-10-31) — Gross PPE: 536791.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Gross PPE: 536791.00
EBM.V income_statement (annual, 2024-10-31) — Gross Profit: 454389.00
EBM.V income_statement (quarterly, 2024-10-31) — Gross Profit: 96807.00
EBM.V income_statement (annual, 2024-10-31) — Insurance And Claims: 71608.00
EBM.V income_statement (quarterly, 2024-10-31) — Insurance And Claims: 16441.00
EBM.V income_statement (annual, 2024-10-31) — Interest Expense: 6286.00
EBM.V income_statement (annual, 2024-10-31) — Interest Expense Non Operating: 6286.00
EBM.V balance_sheet (annual, 2024-10-31) — Invested Capital: -1217058.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Invested Capital: -1217058.00
EBM.V cash_flow (annual, 2024-10-31) — Issuance Of Debt: 39356.00
EBM.V balance_sheet (annual, 2024-10-31) — Leases: 216901.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Leases: 216901.00
EBM.V balance_sheet (annual, 2024-10-31) — Line Of Credit: 19608.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Line Of Credit: 19608.00
EBM.V balance_sheet (annual, 2024-10-31) — Net Debt: 79608.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Net Debt: 79608.00
EBM.V cash_flow (annual, 2024-10-31) — Net Foreign Currency Exchange Gain Loss: -244.00
EBM.V income_statement (annual, 2024-10-31) — Net Income: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income: -155944.00
EBM.V income_statement (annual, 2024-10-31) — Net Income Common Stockholders: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income Common Stockholders: -155944.00
EBM.V income_statement (annual, 2024-10-31) — Net Income Continuous Operations: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income Continuous Operations: -155940.00
EBM.V income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -155944.00
EBM.V income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: -155944.00
EBM.V cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: -455870.00
EBM.V cash_flow (quarterly, 2024-10-31) — Net Income From Continuing Operations: -155944.00
EBM.V income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Income Including Noncontrolling Interests: -155940.00
EBM.V income_statement (annual, 2024-10-31) — Net Interest Income: -6286.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Interest Income: -1226.00
EBM.V cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: -4619.00
EBM.V cash_flow (quarterly, 2024-10-31) — Net Issuance Payments Of Debt: -6531.00
EBM.V income_statement (annual, 2024-10-31) — Net Non Operating Interest Income Expense: -6286.00
EBM.V income_statement (quarterly, 2024-10-31) — Net Non Operating Interest Income Expense: -1226.00
EBM.V balance_sheet (annual, 2024-10-31) — Net PPE: 230613.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Net PPE: 230613.00
EBM.V cash_flow (annual, 2024-10-31) — Net Short Term Debt Issuance: -4619.00
EBM.V cash_flow (quarterly, 2024-10-31) — Net Short Term Debt Issuance: -6531.00
EBM.V balance_sheet (annual, 2024-10-31) — Net Tangible Assets: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: -1296666.00
EBM.V income_statement (annual, 2024-10-31) — Normalized EBITDA: -318274.00
EBM.V income_statement (quarterly, 2024-10-31) — Normalized EBITDA: -106398.00
EBM.V income_statement (annual, 2024-10-31) — Normalized Income: -443986.00
EBM.V income_statement (quarterly, 2024-10-31) — Normalized Income: -139662.00
EBM.V cash_flow (annual, 2024-10-31) — Operating Cash Flow: -15217.00
EBM.V cash_flow (quarterly, 2024-10-31) — Operating Cash Flow: -7872.00
EBM.V cash_flow (annual, 2024-10-31) — Operating Gains Losses: -244.00
EBM.V income_statement (annual, 2024-10-31) — Operating Income: -437700.00
EBM.V income_statement (quarterly, 2024-10-31) — Operating Income: -138432.00
EBM.V income_statement (annual, 2024-10-31) — Operating Revenue: 702076.00
EBM.V income_statement (quarterly, 2024-10-31) — Operating Revenue: 177614.00
EBM.V balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (annual, 2024-10-31) — Other Current Borrowings: 60000.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Other Current Borrowings: 60000.00
EBM.V income_statement (annual, 2024-10-31) — Other Gand A: 82433.00
EBM.V income_statement (quarterly, 2024-10-31) — Other Gand A: 23757.00
EBM.V income_statement (annual, 2024-10-31) — Other Income Expense: -11884.00
EBM.V income_statement (quarterly, 2024-10-31) — Other Income Expense: -16282.00
EBM.V cash_flow (annual, 2024-10-31) — Other Non Cash Items: 21118.00
EBM.V cash_flow (quarterly, 2024-10-31) — Other Non Cash Items: -7799.00
EBM.V income_statement (annual, 2024-10-31) — Other Operating Expenses: 257472.00
EBM.V income_statement (quarterly, 2024-10-31) — Other Operating Expenses: 85292.00
EBM.V balance_sheet (annual, 2024-10-31) — Other Properties: 319890.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Other Properties: 319890.00
EBM.V balance_sheet (annual, 2024-10-31) — Payables: 1474732.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Payables: 1474732.00
EBM.V balance_sheet (annual, 2024-10-31) — Payables And Accrued Expenses: 1474732.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Payables And Accrued Expenses: 1474732.00
EBM.V balance_sheet (annual, 2024-10-31) — Prepaid Assets: 797.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 797.00
EBM.V income_statement (annual, 2024-10-31) — Pretax Income: -455870.00
EBM.V income_statement (quarterly, 2024-10-31) — Pretax Income: -155940.00
EBM.V balance_sheet (annual, 2024-10-31) — Properties: 0.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Properties: 0.00
EBM.V balance_sheet (annual, 2024-10-31) — Receivables: 42883.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Receivables: 42883.00
EBM.V income_statement (annual, 2024-10-31) — Reconciled Cost Of Revenue: 247687.00
EBM.V income_statement (quarterly, 2024-10-31) — Reconciled Cost Of Revenue: 80807.00
EBM.V income_statement (annual, 2024-10-31) — Reconciled Depreciation: 107542.00
EBM.V income_statement (quarterly, 2024-10-31) — Reconciled Depreciation: 27636.00
EBM.V cash_flow (annual, 2024-10-31) — Repayment Of Debt: -43975.00
EBM.V balance_sheet (annual, 2024-10-31) — Retained Earnings: -5993556.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Retained Earnings: -5993556.00
EBM.V income_statement (annual, 2024-10-31) — Salaries And Wages: 370029.00
EBM.V income_statement (quarterly, 2024-10-31) — Salaries And Wages: 81765.00
EBM.V income_statement (annual, 2024-10-31) — Selling And Marketing Expense: 3005.00
EBM.V income_statement (quarterly, 2024-10-31) — Selling And Marketing Expense: 348.00
EBM.V income_statement (annual, 2024-10-31) — Selling General And Administration: 527075.00
EBM.V income_statement (quarterly, 2024-10-31) — Selling General And Administration: 122311.00
EBM.V balance_sheet (annual, 2024-10-31) — Share Issued: 68885969.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Share Issued: 68885969.00
EBM.V cash_flow (annual, 2024-10-31) — Short Term Debt Issuance: 39356.00
EBM.V cash_flow (annual, 2024-10-31) — Short Term Debt Payments: -43975.00
EBM.V income_statement (annual, 2024-10-31) — Special Income Charges: -4679.00
EBM.V income_statement (quarterly, 2024-10-31) — Special Income Charges: -4679.00
EBM.V balance_sheet (annual, 2024-10-31) — Stockholders Equity: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: -1296666.00
EBM.V balance_sheet (annual, 2024-10-31) — Tangible Book Value: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: -1296666.00
EBM.V income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
EBM.V income_statement (quarterly, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
EBM.V income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.00
EBM.V income_statement (quarterly, 2024-10-31) — Tax Rate For Calcs: 0.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Assets: 274293.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Assets: 274293.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Capitalization: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Capitalization: -1296666.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Debt: 79608.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Debt: 79608.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: -1296666.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: -1296666.00
EBM.V income_statement (annual, 2024-10-31) — Total Expenses: 1139776.00
EBM.V income_statement (quarterly, 2024-10-31) — Total Expenses: 316046.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 1570959.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 1570959.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Non Current Assets: 230613.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Non Current Assets: 230613.00
EBM.V balance_sheet (annual, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EBM.V income_statement (annual, 2024-10-31) — Total Other Finance Cost: 6286.00
EBM.V income_statement (annual, 2024-10-31) — Total Unusual Items: -11884.00
EBM.V income_statement (quarterly, 2024-10-31) — Total Unusual Items: -16282.00
EBM.V income_statement (annual, 2024-10-31) — Total Unusual Items Excluding Goodwill: -11884.00
EBM.V income_statement (quarterly, 2024-10-31) — Total Unusual Items Excluding Goodwill: -16282.00
EBM.V balance_sheet (annual, 2024-10-31) — Working Capital: -1527279.00
EBM.V balance_sheet (quarterly, 2024-10-31) — Working Capital: -1527279.00
EBM.V income_statement (annual, 2024-10-31) — Write Off: 4679.00
EBM.V income_statement (quarterly, 2024-10-31) — Write Off: 4679.00
EBM.V income_statement (quarterly, 2025-01-31) — +Operating Expense: 199254.00
EBM.V income_statement (quarterly, 2025-01-31) — +Total Revenue: 214720.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 49891.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 8852.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -351141.00
EBM.V income_statement (quarterly, 2025-01-31) — Amortization: 44963.00
EBM.V cash_flow (quarterly, 2025-01-31) — Amortization Cash Flow: 44963.00
EBM.V cash_flow (quarterly, 2025-01-31) — Amortization Of Intangibles: 44963.00
EBM.V income_statement (quarterly, 2025-01-31) — Amortization Of Intangibles Income Statement: 44963.00
EBM.V income_statement (quarterly, 2025-01-31) — Basic Average Shares: 68885969.00
EBM.V income_statement (quarterly, 2025-01-31) — Basic EPS: -0.01
EBM.V cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Capital Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 8624.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 8624.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Cash Financial: 8624.00
EBM.V cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 4552.00
EBM.V cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 4102.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Account Payable: -26954.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -11881.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Payable: -21824.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -21824.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: 0.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Receivables: 34032.00
EBM.V cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 327.00
EBM.V cash_flow (quarterly, 2025-01-31) — Changes In Cash: 8624.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Common Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: -1337854.00
EBM.V income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 55656.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Assets: 18273.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Debt: 82743.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 82743.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 4738.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 4738.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 1541777.00
EBM.V cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 44963.00
EBM.V income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 44963.00
EBM.V cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 44963.00
EBM.V income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 44963.00
EBM.V income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 68885969.00
EBM.V income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.01
EBM.V income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -41188.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Dueto Related Parties Current: 1404405.00
EBM.V income_statement (quarterly, 2025-01-31) — EBIT: -40190.00
EBM.V income_statement (quarterly, 2025-01-31) — EBITDA: 4773.00
EBM.V cash_flow (quarterly, 2025-01-31) — End Cash Position: 8624.00
EBM.V cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 4552.00
EBM.V cash_flow (quarterly, 2025-01-31) — Free Cash Flow: 4102.00
EBM.V income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -198.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 110959.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Gross PPE: 536791.00
EBM.V income_statement (quarterly, 2025-01-31) — Gross Profit: 159064.00
EBM.V income_statement (quarterly, 2025-01-31) — Insurance And Claims: 18278.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Invested Capital: -1255111.00
EBM.V cash_flow (quarterly, 2025-01-31) — Issuance Of Debt: 4552.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Line Of Credit: 22743.00
EBM.V cash_flow (quarterly, 2025-01-31) — Long Term Debt Issuance: 4552.00
EBM.V cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Net Debt: 74119.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income: -41188.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -41188.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -41189.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -41188.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -41188.00
EBM.V cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -41188.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -41189.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Interest Income: -801.00
EBM.V cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: 4552.00
EBM.V cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: 4552.00
EBM.V income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -801.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Net PPE: 185650.00
EBM.V cash_flow (quarterly, 2025-01-31) — Net Short Term Debt Issuance: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: -1337854.00
EBM.V income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 4971.00
EBM.V income_statement (quarterly, 2025-01-31) — Normalized Income: -40990.00
EBM.V cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 4102.00
EBM.V income_statement (quarterly, 2025-01-31) — Operating Income: -40190.00
EBM.V income_statement (quarterly, 2025-01-31) — Operating Revenue: 214720.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Other Current Borrowings: 60000.00
EBM.V income_statement (quarterly, 2025-01-31) — Other Gand A: 2600.00
EBM.V income_statement (quarterly, 2025-01-31) — Other Income Expense: -198.00
EBM.V cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 7778.00
EBM.V income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 43144.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Other Properties: 319890.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Payables: 1454296.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 1454296.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 797.00
EBM.V income_statement (quarterly, 2025-01-31) — Pretax Income: -41189.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Properties: 216901.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Receivables: 8852.00
EBM.V income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 55656.00
EBM.V income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 44963.00
EBM.V cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -6034744.00
EBM.V income_statement (quarterly, 2025-01-31) — Salaries And Wages: 90081.00
EBM.V income_statement (quarterly, 2025-01-31) — Selling And Marketing Expense: 188.00
EBM.V income_statement (quarterly, 2025-01-31) — Selling General And Administration: 111147.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Share Issued: 68885969.00
EBM.V cash_flow (quarterly, 2025-01-31) — Short Term Debt Issuance: 0.00
EBM.V income_statement (quarterly, 2025-01-31) — Special Income Charges: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: -1337854.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: -1337854.00
EBM.V income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
EBM.V income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Assets: 203923.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Capitalization: -1337854.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Debt: 82743.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: -1337854.00
EBM.V income_statement (quarterly, 2025-01-31) — Total Expenses: 254910.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 1541777.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 185650.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EBM.V income_statement (quarterly, 2025-01-31) — Total Other Finance Cost: 801.00
EBM.V income_statement (quarterly, 2025-01-31) — Total Unusual Items: -198.00
EBM.V income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -198.00
EBM.V balance_sheet (quarterly, 2025-01-31) — Working Capital: -1523504.00
EBM.V income_statement (quarterly, 2025-01-31) — Write Off: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — +Operating Expense: 192992.00
EBM.V income_statement (quarterly, 2025-04-30) — +Total Revenue: 76782.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 139838.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 30194.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -351141.00
EBM.V income_statement (quarterly, 2025-04-30) — Amortization: 0.00
EBM.V cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 0.00
EBM.V cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Amortization Of Intangibles Income Statement: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Basic Average Shares: 68885969.00
EBM.V income_statement (quarterly, 2025-04-30) — Basic EPS: -0.01
EBM.V cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 8624.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Capital Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 18960.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 18960.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Cash Financial: 18960.00
EBM.V cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -2625.00
EBM.V cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 12931.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 89947.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 9897.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Payable: 181275.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 181275.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: 0.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Receivables: -21342.00
EBM.V cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 169830.00
EBM.V cash_flow (quarterly, 2025-04-30) — Changes In Cash: 10336.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Common Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: -1494753.00
EBM.V income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 39376.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Assets: 49951.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Debt: 80148.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 80148.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 14635.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 14635.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 1730355.00
EBM.V cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 0.00
EBM.V cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 68885969.00
EBM.V income_statement (quarterly, 2025-04-30) — Diluted EPS: -0.01
EBM.V income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -156898.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Dueto Related Parties Current: 1495734.00
EBM.V income_statement (quarterly, 2025-04-30) — EBIT: -155586.00
EBM.V income_statement (quarterly, 2025-04-30) — EBITDA: -155586.00
EBM.V cash_flow (quarterly, 2025-04-30) — End Cash Position: 18960.00
EBM.V cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -2625.00
EBM.V cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 12931.00
EBM.V income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: -210.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 132981.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Gross PPE: 536791.00
EBM.V income_statement (quarterly, 2025-04-30) — Gross Profit: 37406.00
EBM.V income_statement (quarterly, 2025-04-30) — Insurance And Claims: 15720.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Invested Capital: -1414605.00
EBM.V cash_flow (quarterly, 2025-04-30) — Issuance Of Debt: -4552.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Line Of Credit: 20148.00
EBM.V cash_flow (quarterly, 2025-04-30) — Long Term Debt Issuance: -4552.00
EBM.V cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: 0.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Net Debt: 61188.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income: -156898.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -156898.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -156900.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -156898.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -156898.00
EBM.V cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -156899.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -156900.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Interest Income: -1104.00
EBM.V cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -2625.00
EBM.V cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -4552.00
EBM.V income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -1104.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Net PPE: 185650.00
EBM.V cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: 1927.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: -1494753.00
EBM.V income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -155376.00
EBM.V income_statement (quarterly, 2025-04-30) — Normalized Income: -156688.00
EBM.V cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 12931.00
EBM.V income_statement (quarterly, 2025-04-30) — Operating Income: -155586.00
EBM.V income_statement (quarterly, 2025-04-30) — Operating Revenue: 76782.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Other Current Borrowings: 60000.00
EBM.V income_statement (quarterly, 2025-04-30) — Other Gand A: 40357.00
EBM.V income_statement (quarterly, 2025-04-30) — Other Income Expense: -210.00
EBM.V income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 58447.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Other Properties: 319890.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Payables: 1635572.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 1635572.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 797.00
EBM.V income_statement (quarterly, 2025-04-30) — Pretax Income: -156900.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Properties: 216901.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Receivables: 30194.00
EBM.V income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 39376.00
EBM.V income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 0.00
EBM.V cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: 0.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -6191643.00
EBM.V income_statement (quarterly, 2025-04-30) — Salaries And Wages: 76904.00
EBM.V income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 1564.00
EBM.V income_statement (quarterly, 2025-04-30) — Selling General And Administration: 134545.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Share Issued: 68885969.00
EBM.V income_statement (quarterly, 2025-04-30) — Special Income Charges: 0.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: -1494753.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: -1494753.00
EBM.V income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Assets: 235602.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Capitalization: -1494753.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Debt: 80148.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: -1494753.00
EBM.V income_statement (quarterly, 2025-04-30) — Total Expenses: 232368.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 1730355.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 185650.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 0.00
EBM.V income_statement (quarterly, 2025-04-30) — Total Other Finance Cost: 1104.00
EBM.V income_statement (quarterly, 2025-04-30) — Total Unusual Items: -210.00
EBM.V income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -210.00
EBM.V balance_sheet (quarterly, 2025-04-30) — Working Capital: -1680404.00
EBM.V income_statement (quarterly, 2025-04-30) — Write Off: 0.00
EBM.V cash_flow (quarterly, 2025-07-31) — Net Short Term Debt Issuance: -8812.00
EBM.V income_statement (annual, 2025-10-31) — +Operating Expense: 843321.00
EBM.V income_statement (quarterly, 2025-10-31) — +Operating Expense: 304379.00
EBM.V income_statement (annual, 2025-10-31) — +Total Revenue: 782080.00
EBM.V income_statement (quarterly, 2025-10-31) — +Total Revenue: 365122.00
EBM.V balance_sheet (annual, 2025-10-31) — Accounts Payable: 84464.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 84464.00
EBM.V balance_sheet (annual, 2025-10-31) — Accounts Receivable: 14621.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 14621.00
EBM.V balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -351141.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -351141.00
EBM.V income_statement (annual, 2025-10-31) — Amortization: 44963.00
EBM.V income_statement (quarterly, 2025-10-31) — Amortization: 0.00
EBM.V cash_flow (annual, 2025-10-31) — Amortization Cash Flow: 44963.00
EBM.V cash_flow (quarterly, 2025-10-31) — Amortization Cash Flow: 0.00
EBM.V cash_flow (annual, 2025-10-31) — Amortization Of Intangibles: 44963.00
EBM.V cash_flow (quarterly, 2025-10-31) — Amortization Of Intangibles: 0.00
EBM.V income_statement (annual, 2025-10-31) — Amortization Of Intangibles Income Statement: 44963.00
EBM.V income_statement (quarterly, 2025-10-31) — Amortization Of Intangibles Income Statement: 0.00
EBM.V income_statement (annual, 2025-10-31) — Basic Average Shares: 68885969.00
EBM.V income_statement (annual, 2025-10-31) — Basic EPS: -0.01
EBM.V cash_flow (annual, 2025-10-31) — Beginning Cash Position: -1388.00
EBM.V cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 22032.00
EBM.V balance_sheet (annual, 2025-10-31) — Capital Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Capital Stock: 4687376.00
EBM.V balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 17704.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 17704.00
EBM.V balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 17704.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 17704.00
EBM.V balance_sheet (annual, 2025-10-31) — Cash Financial: 17704.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Cash Financial: 17704.00
EBM.V cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: -211.00
EBM.V cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 6674.00
EBM.V cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: 7287.00
EBM.V cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -21630.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Account Payable: -6008.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -8195.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Other Working Capital: -5511.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -6239.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Payable: 269341.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Payable: 64825.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: 269341.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 64825.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: 0.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 0.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Receivables: 28262.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Receivables: -6346.00
EBM.V cash_flow (annual, 2025-10-31) — Change In Working Capital: 292092.00
EBM.V cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 52240.00
EBM.V cash_flow (annual, 2025-10-31) — Changes In Cash: 19092.00
EBM.V cash_flow (quarterly, 2025-10-31) — Changes In Cash: -2940.00
EBM.V balance_sheet (annual, 2025-10-31) — Common Stock: 4687376.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Common Stock: 4687376.00
EBM.V balance_sheet (annual, 2025-10-31) — Common Stock Equity: -1629433.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: -1629433.00
EBM.V income_statement (annual, 2025-10-31) — Cost Of Revenue: 231087.00
EBM.V income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 97293.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Assets: 33122.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Assets: 33122.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Debt: 78009.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Debt: 78009.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Debt And Capital Lease Obligation: 78009.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 78009.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Deferred Liabilities: 11108.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 11108.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Deferred Revenue: 11108.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 11108.00
EBM.V balance_sheet (annual, 2025-10-31) — Current Liabilities: 1848205.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 1848205.00
EBM.V cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 44963.00
EBM.V cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 0.00
EBM.V income_statement (annual, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 44963.00
EBM.V income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 0.00
EBM.V cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 44963.00
EBM.V cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 0.00
EBM.V income_statement (annual, 2025-10-31) — Depreciation And Amortization In Income Statement: 44963.00
EBM.V income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 0.00
EBM.V income_statement (annual, 2025-10-31) — Diluted Average Shares: 68885969.00
EBM.V income_statement (annual, 2025-10-31) — Diluted EPS: -0.01
EBM.V income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -76869.00
EBM.V balance_sheet (annual, 2025-10-31) — Dueto Related Parties Current: 1674624.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Dueto Related Parties Current: 1674624.00
EBM.V income_statement (annual, 2025-10-31) — EBIT: -292328.00
EBM.V income_statement (quarterly, 2025-10-31) — EBIT: -36550.00
EBM.V income_statement (annual, 2025-10-31) — EBITDA: -247365.00
EBM.V income_statement (quarterly, 2025-10-31) — EBITDA: -36550.00
EBM.V cash_flow (annual, 2025-10-31) — End Cash Position: 17704.00
EBM.V cash_flow (quarterly, 2025-10-31) — End Cash Position: 17704.00
EBM.V cash_flow (annual, 2025-10-31) — Financing Cash Flow: -211.00
EBM.V cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 6674.00
EBM.V cash_flow (annual, 2025-10-31) — Free Cash Flow: 19303.00
EBM.V cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -9614.00
EBM.V income_statement (annual, 2025-10-31) — Gain On Sale Of Security: -30936.00
EBM.V income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: -30579.00
EBM.V balance_sheet (annual, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 9514.00
EBM.V income_statement (annual, 2025-10-31) — General And Administrative Expense: 436912.00
EBM.V income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 99151.00
EBM.V balance_sheet (annual, 2025-10-31) — Gross PPE: 536791.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Gross PPE: 536791.00
EBM.V income_statement (annual, 2025-10-31) — Gross Profit: 550993.00
EBM.V income_statement (quarterly, 2025-10-31) — Gross Profit: 267829.00
EBM.V income_statement (annual, 2025-10-31) — Insurance And Claims: 64544.00
EBM.V income_statement (quarterly, 2025-10-31) — Insurance And Claims: 14836.00
EBM.V balance_sheet (annual, 2025-10-31) — Invested Capital: -1551424.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Invested Capital: -1551424.00
EBM.V cash_flow (annual, 2025-10-31) — Issuance Of Debt: 24413.00
EBM.V balance_sheet (annual, 2025-10-31) — Leases: 216901.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Leases: 216901.00
EBM.V balance_sheet (annual, 2025-10-31) — Line Of Credit: 18009.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Line Of Credit: 18009.00
EBM.V balance_sheet (annual, 2025-10-31) — Net Debt: 60305.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Net Debt: 60305.00
EBM.V cash_flow (annual, 2025-10-31) — Net Foreign Currency Exchange Gain Loss: 0.00
EBM.V income_statement (annual, 2025-10-31) — Net Income: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income: -76869.00
EBM.V income_statement (annual, 2025-10-31) — Net Income Common Stockholders: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -76869.00
EBM.V income_statement (annual, 2025-10-31) — Net Income Continuous Operations: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -76871.00
EBM.V income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -76869.00
EBM.V income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -76869.00
EBM.V cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: -332767.00
EBM.V cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -76869.00
EBM.V income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -76871.00
EBM.V income_statement (annual, 2025-10-31) — Net Interest Income: -9006.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Interest Income: -9245.00
EBM.V cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -211.00
EBM.V cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: 6674.00
EBM.V income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: -9006.00
EBM.V income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -9245.00
EBM.V balance_sheet (annual, 2025-10-31) — Net PPE: 185650.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Net PPE: 185650.00
EBM.V cash_flow (annual, 2025-10-31) — Net Short Term Debt Issuance: -211.00
EBM.V cash_flow (quarterly, 2025-10-31) — Net Short Term Debt Issuance: 6674.00
EBM.V balance_sheet (annual, 2025-10-31) — Net Tangible Assets: -1629433.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: -1629433.00
EBM.V income_statement (annual, 2025-10-31) — Normalized EBITDA: -215932.00
EBM.V income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -5474.00
EBM.V income_statement (annual, 2025-10-31) — Normalized Income: -301334.00
EBM.V income_statement (quarterly, 2025-10-31) — Normalized Income: -45793.00
EBM.V cash_flow (annual, 2025-10-31) — Operating Cash Flow: 19303.00
EBM.V cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -9614.00
EBM.V income_statement (annual, 2025-10-31) — Operating Income: -292328.00
EBM.V income_statement (quarterly, 2025-10-31) — Operating Income: -36550.00
EBM.V income_statement (annual, 2025-10-31) — Operating Revenue: 782080.00
EBM.V income_statement (quarterly, 2025-10-31) — Operating Revenue: 365122.00
EBM.V balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 68885969.00
EBM.V balance_sheet (annual, 2025-10-31) — Other Current Borrowings: 60000.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 60000.00
EBM.V income_statement (annual, 2025-10-31) — Other Gand A: 58509.00
EBM.V income_statement (quarterly, 2025-10-31) — Other Gand A: 9284.00
EBM.V income_statement (annual, 2025-10-31) — Other Income Expense: -31433.00
EBM.V income_statement (quarterly, 2025-10-31) — Other Income Expense: -31076.00
EBM.V cash_flow (annual, 2025-10-31) — Other Non Cash Items: 15015.00
EBM.V income_statement (annual, 2025-10-31) — Other Operating Expenses: 191507.00
EBM.V income_statement (quarterly, 2025-10-31) — Other Operating Expenses: 45883.00
EBM.V balance_sheet (annual, 2025-10-31) — Other Properties: 319890.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Other Properties: 319890.00
EBM.V balance_sheet (annual, 2025-10-31) — Payables: 1759088.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Payables: 1759088.00
EBM.V balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 1759088.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 1759088.00
EBM.V balance_sheet (annual, 2025-10-31) — Prepaid Assets: 797.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 797.00
EBM.V income_statement (annual, 2025-10-31) — Pretax Income: -332767.00
EBM.V income_statement (quarterly, 2025-10-31) — Pretax Income: -76871.00
EBM.V balance_sheet (annual, 2025-10-31) — Properties: 0.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
EBM.V balance_sheet (annual, 2025-10-31) — Receivables: 14621.00
EBM.V balance_sheet (quarterly, 2025-10-31) — Receivables: 14621.00